Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 181

1.

Quality of reporting in abstracts of RCTs published in emergency medicine journals: a systematic survey of the literature suggests we can do better.

Germini F, Marcucci M, Fedele M, Galli MG, Heath T, Mbuagbaw L, Salvatori V, Veronese G, Worster A, Thabane L.

Emerg Med J. 2019 Nov 6. pii: emermed-2019-208629. doi: 10.1136/emermed-2019-208629. [Epub ahead of print]

PMID:
31694858
2.

PATZ1 Is Overexpressed in Pediatric Glial Tumors and Correlates with Worse Event-Free Survival in High-grade Gliomas.

Passariello A, Errico ME, Donofrio V, Maestrini M, Zerbato A, Cerchia L, Capasso M, Capasso M, Fedele M.

Cancers (Basel). 2019 Oct 11;11(10). pii: E1537. doi: 10.3390/cancers11101537.

3.

Chemical hazard for dental hygienists: a systematic review.

Lajolo C, Leso V, Gioco G, Patini R, Fedele M, Giuliani M, Iavicoli I.

Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):7713-7721. doi: 10.26355/eurrev_201909_18980.

4.

Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma.

Fedele M, Cerchia L, Pegoraro S, Sgarra R, Manfioletti G.

Int J Mol Sci. 2019 Jun 4;20(11). pii: E2746. doi: 10.3390/ijms20112746. Review.

5.

Retraction: FRA-1 Expression in Hyperplastic and Neoplastic Thyroid Diseases.

Chiappetta G, Tallini G, De Biasio MC, Pentimalli F, de Nigris F, Losito S, Fedele M, Battista S, Verde P, Santoro M, Fusco A.

Clin Cancer Res. 2019 Apr 15;25(8):2675. doi: 10.1158/1078-0432.CCR-19-0487. No abstract available.

PMID:
30988099
6.

Dual Oncogenic/Anti-Oncogenic Role of PATZ1 in FRTL5 Rat Thyroid Cells Transformed by the Ha-RasV12 Oncogene.

Vitiello M, Palma G, Monaco M, Bello AM, Camorani S, Francesca P, Rea D, Barbieri A, Chiappetta G, Vita G, Cerchia L, Arra C, Fedele M.

Genes (Basel). 2019 Feb 9;10(2). pii: E127. doi: 10.3390/genes10020127.

7.

The Impact of Left Atrium Appendage Morphology on Stroke Risk Assessment in Atrial Fibrillation: A Computational Fluid Dynamics Study.

Masci A, Barone L, Dedè L, Fedele M, Tomasi C, Quarteroni A, Corsi C.

Front Physiol. 2019 Jan 22;9:1938. doi: 10.3389/fphys.2018.01938. eCollection 2018.

8.

Acute Infectious Diarrhea.

Lo Vecchio A, Buccigrossi V, Fedele MC, Guarino A.

Adv Exp Med Biol. 2019;1125:109-120. doi: 10.1007/5584_2018_320.

PMID:
30649712
9.

Retraction: Haploinsufficiency of the Hmga1 Gene Causes Cardiac Hypertrophy and Myelo-Lymphoproliferative Disorders in Mice.

Fedele M, Fidanza V, Battista S, Pentimalli F, Klein-Szanto AJP, Visone R, De Martino I, Curcio A, Morisco C, Del Vecchio L, Baldassarre G, Arra C, Viglietto G, Indolfi C, Croce CM, Fusco A.

Cancer Res. 2018 Dec 15;78(24):6908. doi: 10.1158/0008-5472.CAN-18-3457. No abstract available.

PMID:
30552126
10.

Retraction: HMGA Proteins Up-regulate CCNB2 Gene in Mouse and Human Pituitary Adenomas.

De Martino I, Visone R, Wierinckx A, Palmieri D, Ferraro A, Cappabianca P, Chiappetta G, Forzati F, Lombardi G, Colao A, Trouillas J, Fedele M, Fusco A.

Cancer Res. 2018 Dec 15;78(24):6906. doi: 10.1158/0008-5472.CAN-18-3455. No abstract available.

PMID:
30552124
11.

'Frequently recurring' nocturnal polyuria is predictive of response to desmopressin in monosymptomatic nocturnal enuresis in childhood.

Marzuillo P, Marotta R, Guarino S, Fedele MC, Palladino F, Capalbo D, Della Vecchia N, Miraglia Del Giudice E, Polito C, La Manna A.

J Pediatr Urol. 2019 Apr;15(2):166.e1-166.e7. doi: 10.1016/j.jpurol.2018.11.004. Epub 2018 Nov 14.

PMID:
30528650
12.

Determinants of low measles vaccination coverage in children living in an endemic area.

Lo Vecchio A, Cambriglia MD, Fedele MC, Basile FW, Chiatto F, Miraglia Del Giudice M, Guarino A.

Eur J Pediatr. 2019 Feb;178(2):243-251. doi: 10.1007/s00431-018-3289-5. Epub 2018 Nov 14.

PMID:
30430239
13.

Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer.

Camorani S, Hill BS, Collina F, Gargiulo S, Napolitano M, Cantile M, Di Bonito M, Botti G, Fedele M, Zannetti A, Cerchia L.

Theranostics. 2018 Oct 6;8(18):5178-5199. doi: 10.7150/thno.27798. eCollection 2018.

14.

TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities.

Camorani S, Fedele M, Zannetti A, Cerchia L.

Pharmaceuticals (Basel). 2018 Nov 13;11(4). pii: E123. doi: 10.3390/ph11040123. Review.

15.

Trabectedin modulates the senescence-associated secretory phenotype and promotes cell death in senescent tumor cells by targeting NF-κB.

Camorani S, Cerchia L, Fedele M, Erba E, D'Incalci M, Crescenzi E.

Oncotarget. 2018 Apr 13;9(28):19929-19944. doi: 10.18632/oncotarget.24961. eCollection 2018 Apr 13.

16.

A 23-month-old girl with chronic 'seborrhoeic' dermatitis, dehydration and failure to thrive.

Marzuillo P, Grandone A, Guarino S, Apicella A, Panarese I, Picciano L, Fedele MC, Palladino F, Perrotta S, Miraglia Del Giudice E.

Arch Dis Child Educ Pract Ed. 2019 Jun;104(3):154-156. doi: 10.1136/archdischild-2018-314828. Epub 2018 Apr 27. No abstract available.

PMID:
29703813
17.

Loss of One or Two PATZ1 Alleles Has a Critical Role in the Progression of Thyroid Carcinomas Induced by the RET/PTC1 Oncogene.

Monaco M, Palma G, Vitiello M, Capiluongo A, D'Andrea B, Vuttariello E, Luciano A, Cerchia L, Chiappetta G, Arra C, Fusco A, Fedele M.

Cancers (Basel). 2018 Mar 27;10(4). pii: E92. doi: 10.3390/cancers10040092.

18.

Oligonucleotide aptamers against tyrosine kinase receptors: Prospect for anticancer applications.

Camorani S, Crescenzi E, Fedele M, Cerchia L.

Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):263-277. doi: 10.1016/j.bbcan.2018.03.003. Epub 2018 Mar 21. Review.

PMID:
29574128
19.

Retraction for Melillo et al., "Critical Role of the HMGI(Y) Proteins in Adipocytic Cell Growth and Differentiation".

Melillo RM, Pierantoni GM, Scala S, Battista S, Fedele M, Stella A, De Biasio MC, Chiappetta G, Fidanza V, Condorelli G, Santoro M, Croce CM, Viglietto G, Fusco A.

Mol Cell Biol. 2018 Feb 27;38(6). pii: e00660-17. doi: 10.1128/MCB.00660-17. Print 2018 Mar 15. No abstract available.

20.

Inverse problem for multispecies ferromagneticlike mean-field models in phase space with many states.

Fedele M, Vernia C.

Phys Rev E. 2017 Oct;96(4-1):042135. doi: 10.1103/PhysRevE.96.042135. Epub 2017 Oct 16.

PMID:
29347521
21.

The POZ/BTB and AT-Hook Containing Zinc Finger 1 (PATZ1) Transcription Regulator: Physiological Functions and Disease Involvement.

Fedele M, Crescenzi E, Cerchia L.

Int J Mol Sci. 2017 Nov 24;18(12). pii: E2524. doi: 10.3390/ijms18122524. Review.

22.

HMGA2 cooperates with either p27kip1 deficiency or Cdk4R24C mutation in pituitary tumorigenesis.

Fedele M, Paciello O, De Biase D, Monaco M, Chiappetta G, Vitiello M, Barbieri A, Rea D, Luciano A, Papparella S, Arra C, Fusco A.

Cell Cycle. 2018;17(5):580-588. doi: 10.1080/15384101.2017.1403682. Epub 2018 Jan 30.

23.

The Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas.

Fedele M, Cerchia L, Chiappetta G.

Cancers (Basel). 2017 Sep 30;9(10). pii: E134. doi: 10.3390/cancers9100134. Review.

24.

PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype.

Guadagno E, Vitiello M, Francesca P, Calì G, Caponnetto F, Cesselli D, Camorani S, Borrelli G, Califano M, Cappabianca P, Arra C, Crescenzi E, Cerchia L, De Caro MLDB, Fedele M.

Oncotarget. 2017 Jul 25;8(35):59282-59300. doi: 10.18632/oncotarget.19546. eCollection 2017 Aug 29.

25.

A patient-specific aortic valve model based on moving resistive immersed implicit surfaces.

Fedele M, Faggiano E, Dedè L, Quarteroni A.

Biomech Model Mechanobiol. 2017 Oct;16(5):1779-1803. doi: 10.1007/s10237-017-0919-1. Epub 2017 Jun 7.

PMID:
28593469
26.

Fractional flow reserve based on computed tomography: an overview.

Secchi F, Alì M, Faggiano E, Cannaò PM, Fedele M, Tresoldi S, Di Leo G, Auricchio F, Sardanelli F.

Eur Heart J Suppl. 2016 Apr 28;18(Suppl E):E49-E56. doi: 10.1093/eurheartj/suw014. Epub 2016 Apr 29.

PMID:
28533717
27.

Quality of reporting in abstracts of RCTs published in emergency medicine journals: a protocol for a systematic survey of the literature.

Germini F, Marcucci M, Fedele M, Galli MG, Mbuagbaw L, Salvatori V, Veronese G, Worster A, Thabane L.

BMJ Open. 2017 Apr 27;7(4):e014981. doi: 10.1136/bmjopen-2016-014981. Review.

28.

Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers.

Camorani S, Crescenzi E, Gramanzini M, Fedele M, Zannetti A, Cerchia L.

Sci Rep. 2017 Apr 20;7:46659. doi: 10.1038/srep46659.

29.

POZ-, AT-hook-, and zinc finger-containing protein (PATZ) interacts with the human oncogene B cell lymphoma 6 (BCL6) and is required for its negative autoregulation.

Pero R, Palmieri D, Angrisano T, Valentino T, Federico A, Franco R, Lembo F, Klein-Szanto AJ, Del Vecchio L, Montanaro D, Keller S, Arra C, Papadopoulou V, Wagner SD, Croce CM, Fusco A, Chiariotti L, Fedele M.

J Biol Chem. 2017 Mar 31;292(13):5609. doi: 10.1074/jbc.A117.346270. No abstract available.

30.

Complementary actions of dopamine D2 receptor agonist and anti-vegf therapy on tumoral vessel normalization in a transgenic mouse model.

Chauvet N, Romanò N, Lafont C, Guillou A, Galibert E, Bonnefont X, Le Tissier P, Fedele M, Fusco A, Mollard P, Coutry N.

Int J Cancer. 2017 May 1;140(9):2150-2161. doi: 10.1002/ijc.30628. Epub 2017 Feb 14.

31.

Animal Models of Human Pathology 2016.

Fedele M, Gualillo O, Vecchione A.

Biomed Res Int. 2016;2016:4023982. doi: 10.1155/2016/4023982. Epub 2016 Dec 22. No abstract available.

32.

A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expression.

Chiefari E, Ventura V, Capula C, Randazzo G, Scorcia V, Fedele M, Arcidiacono B, Nevolo MT, Bilotta FL, Vitiello M, Palmieri C, Gulletta E, Fusco A, Foti D, Vero R, Brunetti A.

Sci Rep. 2016 Dec 19;6:39429. doi: 10.1038/srep39429.

33.

Regulation of microRNA expression by HMGA1 proteins.

De Martino I, Visone R, Fedele M, Petrocca F, Palmieri D, Hoyos JM, Forzati F, Croce CM, Fusco A.

Oncogene. 2016 Nov 3;35(44):5817-5818. doi: 10.1038/onc.2016.136. Epub 2016 Jul 11. No abstract available.

PMID:
27399337
34.

Factors Affecting Outcome of Tuberculosis in Children in Italy: An Ecological Study.

Nicastro E, Scotto R, Cerullo D, Fedele MC, Bruzzese E, Giacomet V, Spagnuolo MI, Guarino A, Lo Vecchio A.

Adv Exp Med Biol. 2017;973:71-79. doi: 10.1007/5584_2016_94.

PMID:
27677276
35.

PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas.

Franco R, Scognamiglio G, Valentino E, Vitiello M, Luciano A, Palma G, Arra C, La Mantia E, Panico L, Tenneriello V, Pinto A, Frigeri F, Capobianco G, Botti G, Cerchia L, De Chiara A, Fedele M.

Oncotarget. 2016 Sep 13;7(37):59158-59172. doi: 10.18632/oncotarget.10993.

36.

Randomised clinical trial: a Lactobacillus GG and micronutrient-containing mixture is effective in reducing nosocomial infections in children, vs. placebo.

Bruzzese E, Fedele MC, Bruzzese D, Viscovo S, Giannattasio A, Mandato C, Siani P, Guarino A.

Aliment Pharmacol Ther. 2016 Sep;44(6):568-75. doi: 10.1111/apt.13740. Epub 2016 Jul 28.

37.

HAND1 gene expression is negatively regulated by the High Mobility Group A1 proteins and is drastically reduced in human thyroid carcinomas.

Hoyos JM, Ferraro A, Sacchetti S, Keller S, De Martino I, Borbone E, Pallante P, Fedele M, Montanaro D, Esposito F, Cserjesi P, Chiariotti L, Troncone G, Fusco A.

Oncogene. 2016 Nov 10;35(45):5930. doi: 10.1038/onc.2016.137. Epub 2016 Jun 27. No abstract available.

PMID:
27345408
38.

11/20 L'occlusion intestinale.

Naline C, Fedele M, de Malherbe A, Cudennec T.

Soins Gerontol. 2016 May-Jun;(119):47-8. doi: 10.1016/j.sger.2016.03.011. French. No abstract available.

PMID:
27173633
39.

PATZ1 is a target of miR-29b that is induced by Ha-Ras oncogene in rat thyroid cells.

Vitiello M, Valentino T, De Menna M, Crescenzi E, Francesca P, Rea D, Arra C, Fusco A, De Vita G, Cerchia L, Fedele M.

Sci Rep. 2016 Apr 29;6:25268. doi: 10.1038/srep25268.

40.

Padua prediction score or clinical judgment for decision making on antithrombotic prophylaxis: a quasi-randomized controlled trial.

Germini F, Agnelli G, Fedele M, Galli MG, Giustozzi M, Marcucci M, Paganelli G, Pinotti E, Becattini C.

J Thromb Thrombolysis. 2016 Oct;42(3):336-9. doi: 10.1007/s11239-016-1358-z.

PMID:
27052516
41.

Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.

Camorani S, Crescenzi E, Colecchia D, Carpentieri A, Amoresano A, Fedele M, Chiariello M, Cerchia L.

Oncotarget. 2015 Nov 10;6(35):37570-87. doi: 10.18632/oncotarget.6066.

42.

Animal Models of Human Pathology 2014.

Fedele M, Gualillo O, Vecchione A.

Biomed Res Int. 2015;2015:721348. doi: 10.1155/2015/721348. Epub 2015 Jul 12. No abstract available.

43.

Transcriptional and post-transcriptional regulation of transmembrane protein 132A.

Oh-Hashi K, Sone A, Hikiji T, Hirata Y, Vitiello M, Fedele M, Ishigaki S, Sobue G, Kiuchi K.

Mol Cell Biochem. 2015 Jul;405(1-2):291-9. doi: 10.1007/s11010-015-2419-x. Epub 2015 Apr 30.

PMID:
25926156
44.

Enhancing participation to health screening campaigns by group interactions.

Burioni R, Contucci P, Fedele M, Vernia C, Vezzani A.

Sci Rep. 2015 Apr 23;5:9904. doi: 10.1038/srep09904.

45.

Feasibility of romiplostim discontinuation in adult thrombopoietin-receptor agonist responsive patients with primary immune thrombocytopenia: an observational retrospective report in real life clinical practice.

Carpenedo M, Cantoni S, Coccini V, Fedele M, Morra E, Pogliani EM.

Hematol Rep. 2015 Feb 24;7(1):5673. doi: 10.4081/hr.2015.5673. eCollection 2015 Feb 24.

46.

PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration.

Chiappetta G, Valentino T, Vitiello M, Pasquinelli R, Monaco M, Palma G, Sepe R, Luciano A, Pallante P, Palmieri D, Aiello C, Rea D, Losito SN, Arra C, Fusco A, Fedele M.

Oncotarget. 2015 Mar 10;6(7):5310-23.

47.

The dosage of Patz1 modulates reprogramming process.

Ma H, Ow JR, Tan BC, Goh Z, Feng B, Loh YH, Fedele M, Li H, Wu Q.

Sci Rep. 2014 Dec 17;4:7519. doi: 10.1038/srep07519.

48.

CBX7 gene expression plays a negative role in adipocyte cell growth and differentiation.

Forzati F, Federico A, Pallante P, Colamaio M, Esposito F, Sepe R, Gargiulo S, Luciano A, Arra C, Palma G, Bon G, Bucher S, Falcioni R, Brunetti A, Battista S, Fedele M, Fusco A.

Biol Open. 2014 Sep 4;3(9):871-9. doi: 10.1242/bio.20147872.

49.

Interaction between HMGA1 and retinoblastoma protein is required for adipocyte differentiation.

Esposito F, Pierantoni GM, Battista S, Melillo RM, Scala S, Chieffi P, Fedele M, Fusco A.

J Biol Chem. 2014 Jun 20;289(25):17425. doi: 10.1074/jbc.A109.034280.

50.

Hmga1/Hmga2 double knock-out mice display a "superpygmy" phenotype.

Federico A, Forzati F, Esposito F, Arra C, Palma G, Barbieri A, Palmieri D, Fedele M, Pierantoni GM, De Martino I, Fusco A.

Biol Open. 2014 Apr 11;3(5):372-8. doi: 10.1242/bio.20146759.

Supplemental Content

Loading ...
Support Center